{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:09:03Z","timestamp":1790248143029,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":6067,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.nurt.2006.10.003","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T14:22:02Z","timestamp":1168266122000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain"],"prefix":"10.1016","volume":"4","author":[{"given":"Alan B.","family":"Ettinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Argoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2006.10.003_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.137.7.782","article-title":"Carbamazepine in manic-depressive illness: a new treatment","volume":"137","author":"Ballenger","year":"1980","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14656566.7.4.401","article-title":"Anticonvulsants in the treatment of bipolar mania","volume":"7","author":"Goodnick","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.nurt.2006.10.003_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.nurt.2006.10.003_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/appi.ajp.160.2.237","article-title":"Depression, IV: STAR*D treatment trial for depression","volume":"160","author":"Rush","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.schbul.a006989","article-title":"Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial","volume":"29","author":"Swartz","year":"2003","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.nurt.2006.10.003_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/01.WNL.0000049930.93113.20","article-title":"PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy","volume":"60","author":"Toczek","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","article-title":"Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment","volume":"57","author":"Sargent","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(97)00288-7","article-title":"Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships","volume":"226","author":"Dailey","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nurt.2006.10.003_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(91)90681-F","article-title":"The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo","volume":"200","author":"Whitton","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)11088-4","article-title":"Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats","volume":"261","author":"Yan","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nurt.2006.10.003_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-1211(95)00035-9","article-title":"Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve","volume":"22","author":"Naritoku","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nurt.2006.10.003_bib13","first-page":"2424","article-title":"Loss of anticonvulsant effect of vagus nerve stimulation in the pentylenetetrazol seizure model following treatment with 6-hydroxydopamine or 5,7-dihyrdroxy-tryptamine","volume":"23","author":"Browning","year":"1997","journal-title":"Soc Neurosci"},{"key":"10.1016\/j.nurt.2006.10.003_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4088\/JCP.v66n0902","article-title":"Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes","volume":"66","author":"Nahas","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib15","first-page":"21","article-title":"Adverse neuropsychiatric effects of anticonvulsant drugs","volume":"23","author":"Reynolds","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.nurt.2006.10.003_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archneur.1989.00520420118033","article-title":"Benzodiazepine withdrawal delirium with catatonic features","volume":"46","author":"Hauser","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2006.10.003_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder","volume":"44","author":"Findling","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-0327(01)00434-7","article-title":"Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression","volume":"67","author":"Winsberg","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00019442-200102000-00009","article-title":"Placebo-controlled study of divalproex sodium for agitation in dementia","volume":"9","author":"Porsteinsson","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/gps.653","article-title":"Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial","volume":"17","author":"Sival","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib22","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.npp.1300153","article-title":"Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nurt.2006.10.003_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/070674379804300109","article-title":"Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy","volume":"43","author":"Baetz","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib24","first-page":"134","article-title":"Panic disorder: treatment with valproate","volume":"55","author":"Woodman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1176\/appi.ajp.157.3.463","article-title":"Phenytoin as an antimanic anticonvulsant: a controlled study","volume":"157","author":"Mishory","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1399-5618.2003.00070.x","article-title":"Prophylactic effect of phenytoin in bipolar disorder: a controlled study","volume":"5","author":"Mishory","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4088\/JCP.v66n0507","article-title":"Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder","volume":"66","author":"Nemets","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1037\/1064-1297.13.1.72","article-title":"A comparison of anticonvulsants in the treatment of impulsive aggression","volume":"13","author":"Stanford","year":"2005","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v65n0511","article-title":"A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Ketter","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"suppl 4","key":"10.1016\/j.nurt.2006.10.003_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1528-1167.2005.463008.x","article-title":"Antiepileptic drugs in mood-disordered patients","volume":"46","author":"Gajwani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2006.10.003_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-199812000-00007","article-title":"Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder","volume":"18","author":"Greil","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4088\/JCP.v64n0206","article-title":"Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients","volume":"64","author":"Hartong","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1528-1157.1999.tb00835.x","article-title":"Two cases of nonconvulsive status epilepticus in association with tiagabine therapy","volume":"40","author":"Ettinger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2006.10.003_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4088\/JCP.v64n1016","article-title":"Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control","volume":"64","author":"Rosenthal","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-5618.2002.01201.x","article-title":"Tiagabine in treatment refractory bipolar disorder: a clinical case series","volume":"4","author":"Suppes","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v60n1107","article-title":"Tiagabine appears not to be efficacious in the treatment of acute mania","volume":"60","author":"Grunze","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","article-title":"Treatment of social phobia with gabapentin: a placebo controlled study","volume":"19","author":"Pande","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib41","first-page":"305","article-title":"Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders","volume":"43;","author":"Chouinard","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.v60n0911","article-title":"A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin","volume":"60","author":"Chatterjee","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/10550490500419110","article-title":"A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal","volume":"15","author":"Mariani","year":"2006","journal-title":"Am J Addict"},{"key":"10.1016\/j.nurt.2006.10.003_bib44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00002512-200320140-00003","article-title":"Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation","volume":"20","author":"Moretti","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nurt.2006.10.003_bib45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.jcp.0000155820.74832.b0","article-title":"Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing","volume":"25","author":"Pohl","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4088\/JCP.v65n0210","article-title":"A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 7","key":"10.1016\/j.nurt.2006.10.003_bib51","first-page":"187","article-title":"Behavioral side effects of levetiracetam","volume":"43","author":"Gates","year":"2002","journal-title":"Epilepsia"},{"issue":"suppl 7","key":"10.1016\/j.nurt.2006.10.003_bib52","first-page":"95","article-title":"Positive psychotropic effects associated with the use of lamotrigine in a clinical setting","volume":"43","author":"McBride","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2006.10.003_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib54","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2006.10.003_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hup.591","article-title":"Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add-on study","volume":"19","author":"Bersani","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib56","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4088\/JCP.v64n0707","article-title":"Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design","volume":"64","author":"Grunze","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v65n0909","article-title":"An open-label study of levetiracetam for the treatment of social anxiety disorder","volume":"65","author":"Simon","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.v66n0512","article-title":"Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial","volume":"66","author":"McElroy","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4088\/JCP.v66n0206","article-title":"A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients","volume":"66","author":"Anand","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(02)00407-X","article-title":"Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode","volume":"79","author":"Benedetti","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1399-5618.2002.02228.x","article-title":"Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design","volume":"4","author":"Hummel","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2004.10.013","article-title":"Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study","volume":"29","author":"Bahk","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1399-5618.1999.10111.x","article-title":"Topiramate as add-on treatment for patients with bipolar mania","volume":"1","author":"Chengappa","year":"1999","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0006-3223(99)00316-9","article-title":"Open-label adjunctive topiramate in the treatment of bipolar disorders","volume":"47","author":"McElroy","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study","volume":"4","author":"McIntyre","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2006.10.003_bib67","first-page":"CD003384","article-title":"Topiramate for acute affective episodes in bipolar disorder","author":"Kamini","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nurt.2006.10.003_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/070674370104600316","article-title":"Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?","volume":"46","author":"Dursun","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yebeh.2003.07.007","article-title":"A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.nurt.2006.10.003_bib70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1440-1754.2003.00180.x","article-title":"Tolerability of topiramate in children and adolescents","volume":"39","author":"Reith","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nurt.2006.10.003_bib71","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1176\/appi.ajp.162.8.1542","article-title":"Topiramate-induced psychosis","volume":"162","author":"Kober","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0004-282X2002000200019","article-title":"Acute psychotic disorders induced by topiramate: report of two cases","volume":"60","author":"Stella","year":"2002","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nurt.2006.10.003_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.3.1.1","article-title":"Behavioural effects of the newer antiepileptic drugs: an update","volume":"3","author":"Besag","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nurt.2006.10.003_bib74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.4088\/JCP.v64n1019c","article-title":"Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient","volume":"64","author":"Hofer","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.genhosppsych.2003.11.004","article-title":"Worsening of psychosis or topiramate-induced adverse event?","volume":"26","author":"Duggal","year":"2004","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib76","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4088\/JCP.v65n1112","article-title":"Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study","volume":"65","author":"Nickel","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2004.11.044","article-title":"Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study","volume":"57","author":"Nickel","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib78","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.jcp.0000088906.24613.76","article-title":"Effects of topiramate on aggressive, self-injurious, and disruptive\/destructive behaviors in the intellectually disabled: an open-label retrospective study","volume":"23","author":"Janowsky","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nurt.2006.10.003_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-244X-4-24","article-title":"Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder","volume":"4","author":"Berlant","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-3223(99)00304-2","article-title":"Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study","volume":"47","author":"Rush","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib81","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biopsych.2005.07.028","article-title":"A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression","volume":"58","author":"George","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.nurt.2006.10.003_bib82","first-page":"S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib83","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib85","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib86","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib88","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week randomized trial","volume":"22","author":"Van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nurt.2006.10.003_bib89","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nurt.2006.10.003_bib90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo-controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib91","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.nurt.2006.10.003_bib92","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"suppl A","key":"10.1016\/j.nurt.2006.10.003_bib93","first-page":"16A","article-title":"Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence","volume":"11","author":"Gilron","year":"2006","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.nurt.2006.10.003_bib94","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1682\/JRRD.2005.05.0082","article-title":"Efficacy of gabapentin in treating chronic phantom limb and residual limb pain","volume":"42","author":"Smith","year":"2005","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.nurt.2006.10.003_bib95","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2001.111006119.x","article-title":"Efficacy of gabapentin in migraine prophylaxis","volume":"41","author":"Mathew","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.nurt.2006.10.003_bib96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00000542-200209000-00007","article-title":"A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy","volume":"97","author":"Dirks","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nurt.2006.10.003_bib97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","article-title":"Carbamazepine in the treatment of neuralgia","volume":"19","author":"Killian","year":"1968","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2006.10.003_bib98","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x","article-title":"A four year double blind study of Tegretol in facial pain","volume":"9","author":"Nicol 1969","year":"1969","journal-title":"Headache"},{"key":"10.1016\/j.nurt.2006.10.003_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-2982.1986.0603181.x","article-title":"Tizanidine in the management of trigeminal neuralgia","volume":"6","author":"Vilming","year":"1986","journal-title":"Cephalgia"},{"key":"10.1016\/j.nurt.2006.10.003_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(87)91058-X","article-title":"The analgesic effect of tocainide in trigeminal neuralgia","volume":"28","author":"Lindsrom","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib101","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archneur.1989.00520450030015","article-title":"Pimozide therapy for trigeminal neuralgia","volume":"46","author":"Lechin","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2006.10.003_bib102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01212087","article-title":"Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study","volume":"5","author":"Rull","year":"1969","journal-title":"Diabetologia"},{"key":"10.1016\/j.nurt.2006.10.003_bib103","first-page":"45","article-title":"Central post-stroke pain- a controlled trial of amitriptyline and carbamazepine","volume":"28","author":"Leijon","year":"1989","journal-title":"Pain"},{"issue":"suppl 1","key":"10.1016\/j.nurt.2006.10.003_bib104","first-page":"S57","article-title":"Topiramate in migraine prevention","volume":"45","author":"Silberstein","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.nurt.2006.10.003_bib105","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1526-4610.2002.02183.x","article-title":"Prophylaxis of migraine, transformed migraine and cluster headache with topiramate","volume":"42","author":"Mathew","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.nurt.2006.10.003_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002508-200301000-00008","article-title":"The rationale and use of topiramate for treating neuropathic pain","volume":"19","author":"Chong","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib107","first-page":"221","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo controlled trials","volume":"10","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nurt.2006.10.003_bib108","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib109","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jpain.2005.08.002","article-title":"Topiramate in chronic lumbar radicular pain","volume":"6","author":"Khoromi","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/.ajp.0000192516.58578.a4","article-title":"Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study","volume":"22","author":"Muehlbacher","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1997.1702081.x","article-title":"Clinical studies of valproate for migraine prophylaxis","volume":"17","author":"Rothrock","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nurt.2006.10.003_bib112","first-page":"403","article-title":"Double-blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy","volume":"26","author":"Chadda","year":"1978","journal-title":"J Assoc Physicans India"},{"key":"10.1016\/j.nurt.2006.10.003_bib113","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cpt1977222196","article-title":"Phenytoin in the treatment of diabetic symmetrical neuropathy","volume":"22","author":"Saudek","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nurt.2006.10.003_bib114","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1213\/00000539-199910000-00030","article-title":"Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"89","author":"McCleane","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nurt.2006.10.003_bib115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.56.2.184","article-title":"Lamotrigine for central poststroke pain: a randomized controlled trial","volume":"56","author":"Vestergaard","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib116","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","article-title":"Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial","volume":"60","author":"Simpson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2006.10.003_bib117","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","article-title":"Pharmacotherapy of trigeminal neuralgia","volume":"18","author":"Sindrup","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib119","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0304-3959(01)00484-5","article-title":"Lamotrigine in spinal cord injury pain: a randomized controlled trial","volume":"96","author":"Finnerup","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00095-0","article-title":"200mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind placebo controlled trial","volume":"83","author":"McCleane","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.nurt.2006.10.003_bib121","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.52.4.472","article-title":"Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia","volume":"52","author":"Zakrzewska","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2006.10.003_bib122","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"9","author":"Dogra","year":"2005","journal-title":"Eur J Pain"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2006.10.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:40:21Z","timestamp":1761806421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923006748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1878747923006748"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2006.10.003","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2006.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}